Clincosm LogoSign in Get a demo

Impact of the Implementation of a Clinical Pharmacy Bundle on Intensive Care Unit Patient Outcomes and Cost Expenditures

Sponsor
Centre Hospitalier Universitaire de Nīmes (Other)
Overall Status
Completed
CT.gov ID
NCT02924844
Collaborator
(none)
2,787
Enrollment
28.9
Duration (Months)

Study Details

Study Description

Brief Summary

The aim of this before-after study was to assess the impact of a clinical pharmacy bundle of care activities on patient outcomes (length of hospital stay as a primary endpoint) and cost expenditure in two French ICUs.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    2787 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Impact of the Implementation of a Clinical Pharmacy Bundle on Intensive Care Unit Patient Outcomes and Cost Expenditures
    Study Start Date :
    Jan 1, 2013
    Actual Primary Completion Date :
    Jun 1, 2015
    Actual Study Completion Date :
    Jun 1, 2015

    Arms and Interventions

    Arm Intervention/Treatment
    Observation period before presence of clinical pharmacist

    The group of patients was observed between Janary 2013 and December 2013
    Period with presence of clinical pharmacist

    The group of patients was observed between January 2014 and June 2015.

    Outcome Measures

    Primary Outcome Measures

    1. Length of hospital stay [expected average of 20 days]

    Secondary Outcome Measures

    1. Intensive Care Unit length of stay [Expected maximum of 10 days]

    2. Mechanical ventilation duration [Expected maximum of 10 days]

    3. Intensive care unit mortality rate [Expected maximum of 10 days]

    4. Hospital mortality rate [End of hospital stay (expected average of 20 days)]

    5. Patient cost expenditure [End of hospital stay (expected average of 20 days)]

    Other Outcome Measures

    1. The rate of isolation of multidrug resistant organisms [End of hospital stay (expected average of 20 days)]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Intensive Care Unit patients on weekdays

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Centre Hospitalier Universitaire de Nīmes

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centre Hospitalier Universitaire de Nīmes
    ClinicalTrials.gov Identifier:
    NCT02924844
    Other Study ID Numbers:
    • IRB 14/05.03
    First Posted:
    Oct 5, 2016
    Last Update Posted:
    Oct 5, 2016
    Last Verified:
    Oct 1, 2016

    Study Results

    No Results Posted as of Oct 5, 2016